Geneos Wealth Management’s Hamilton Lane HLNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-306
Closed -$43.5K 2798
2025
Q2
$43.5K Sell
306
-618
-67% -$93.2K ﹤0.01% 1646
2025
Q1
$137K Buy
924
+795
+616% +$121K ﹤0.01% 1396
2024
Q4
$19.1K Buy
129
+8
+7% +$1.43K ﹤0.01% 1749
2024
Q3
$20.4K Buy
+121
New +$17.5K ﹤0.01% 1553

Other funds holding HLNE

Geneos Wealth Management's HLNE Position: Q3 2025 in Review

Geneos Wealth Management sold out of Hamilton Lane (HLNE) in Q3 2025, closing a stake of 306 shares — an estimated $43.5K sold.

Geneos Wealth Management first reported a position in HLNE in Q3 2024 and held it in 4 quarters. The position peaked at $137K in Q1 2025. 382 funds tracked by Wall St. Rank hold HLNE as of Q3 2025.

  • Geneos Wealth Management reported no remaining Hamilton Lane position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 306 Hamilton Lane shares in Q3 2025, an estimated $43.5K.
  • Geneos Wealth Management first reported a position in Hamilton Lane in Q3 2024 and held it in 4 quarters.
  • Geneos Wealth Management's Hamilton Lane position peaked at $137K in Q1 2025.
  • 382 funds tracked by Wall St. Rank held Hamilton Lane as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.